Adma Biologics, Inc.
ADMA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001368514
No open-market purchases or sales by Adma Biologics, Inc. insiders were filed in the last 90 days; 322 institutions reported holding it in 13F filings for Q2 2026, worth $1.70B in total; superinvestors Duquesne Family Office and Fundsmith hold it.
Q1 2023 vs. Q4 2022
How the institutions holding Adma Biologics, Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Of which not filed for Q1 2023 | Q1 2023 | Change |
|---|---|---|---|---|
| Holders | 160 | 4 | 163 | +7 |
| Shares | 152.6M | 80.1K | 165.3M | +12.8M (+8.4%) |
| Value | $592.2M | $310.9K | $547.2M | −$44.6M (−7.5%) |
4 institutions that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (25)
Institutions that held Adma Biologics, Inc. at the end of Q1 2023 but not at the end of Q4 2022.
Sold out (18)
Institutions that held Adma Biologics, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Norges Bank | 1,793,300 | $6.96M |
| EAM Global Investors LLC | 836,323 | $3.24M |
| HRT Financial LP | 621,348 | $2.41M |
| Pura Vida Investments, LLC | 300,000 | $1.16M |
| Potomac Capital Management, Inc. | 120,000 | $466.0K |
| Walleye Capital LLC | 44,323 | $172.0K |
| Stratos Wealth Partners, LTD. | 40,035 | $155.3K |
| ExodusPoint Capital Management, LP | 35,632 | $138.0K |
| Squarepoint Ops LLC | 29,334 | $113.8K |
| AE Wealth Management LLC | 20,385 | $79.1K |
| Two Sigma Securities, LLC | 19,440 | $75.4K |
| Meridian Wealth Management, LLC | 17,000 | $66.0K |
| HSBC Holdings PLC | 14,034 | $54.5K |
| Money Concepts Capital Corp | 3,875 | $15.0K |
| Cutler Group LP | 2,000 | $7.00K |
| Rockefeller Capital Management L.P. | 1,399 | $5.00K |
| US Bancorp | 287 | $1.11K |
| Ellevest, Inc. | 115 | $446 |
Not filed for Q1 2023 yet (4)
Institutions that held Adma Biologics, Inc. at the end of Q4 2022 and haven't filed a 13F for Q1 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Telemetry Investments, L.L.C. | 57,500 | $223.0K |
| Burleson & Company, LLC | 12,407 | $48.1K |
| ARGI Investment Services, LLC | 10,000 | $39.0K |
| Heritage Wealth Management, LLC | 200 | $776 |